SENSIENT TECHNOLOGIES CORP (SXT) Q3 2025 10-Q Quarterly Report

Filed: Nov 4, 2025Period ending Sep 30, 2025
Health Care
Industrial Organic ChemicalsSEC EDGAR

SENSIENT TECHNOLOGIES CORP (SXT) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 4, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

SENSIENT TECHNOLOGIES CORP Q3 2025 10-Q Analysis

Risk Factors

  • Newly added risk: Portfolio Optimization Plan costs increased by $3.3M in Q3 2025, impacting gross margin and operating expenses due to plant closures and restructuring
  • Most materially updated risk: Tariff risk, with new U.S. tariffs enacted raising costs on raw materials and finished goods, potentially materially impacting profitability if not offset by pricing
+3 more insights

SENSIENT TECHNOLOGIES CORP Q3 2025 Quarterly Financials
XBRL

Revenue

$412M

+5.0% YoY -0.5% QoQ

Net Income

$37M

+13.0% YoY -1.7% QoQ

Operating Margin

14.0%

+113bp YoY +7bp QoQ

Net Margin

9.0%

+64bp YoY -11bp QoQ

ROE

3.1%

Total Assets

$2.2B

EPS (Diluted)

$0.87

+13.0% YoY -1.1% QoQ

Operating Cash Flow

$44M

-42.8% YoY -9.0% QoQ

Source: XBRL data from SENSIENT TECHNOLOGIES CORP Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on SENSIENT TECHNOLOGIES CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.